Interaction Between APOE Genotype and Diabetes in Longevity.

Journal of Alzheimer's Disease : JAD
Mitsuru ShinoharaNaoyuki Sato

Abstract

While both apolipoprotein E (APOE) genotype and diabetes affect longevity as well as Alzheimer's disease, their relationship remains to be elucidated. The current study investigated the potential interaction between diabetes and APOE for lifespan and their relationship with cognitive status. We reviewed the National Alzheimer's Coordinating Center (NACC) dataset, which documents longitudinally clinical records of 24,967 individuals with APOE genotype and diabetic status. Diabetes was associated with shorter lifespan in APOE3 carriers (n = 12,415, HR = 1.29, 95%CI = 1.17-1.42, p < 0.001) and APOE2 carriers (n = 2,390, HR = 1.37, 95%CI = 1.10-1.69, p = 0.016), while such associations were weaker and not significant in APOE4 carriers (n = 9,490, HR = 1.11, 95%CI = 0.99-1.24, p = 0.162). As there is a significant interactive effect of cognitive status and diabetes on lifespan (p < 0.001), we stratified subjects by cognitive status and observed persistent APOE-dependent harmful effects of diabetes in nondemented individuals but not demented individuals. Notably, questionnaire-based activity status, with which we previously observed an association between APOE genotype and longevity, was also significantly affected by diabetes only i...Continue Reading

References

Jan 1, 1982·Experimental Gerontology·D K IngramM A Reynolds
Oct 1, 1994·Current Opinion in Neurobiology·R Katzman
Jan 1, 1994·Nature Genetics·F SchächterD Cohen
Jan 1, 1993·Genetic Epidemiology·J A CauleyL H Kuller
Jul 1, 1997·Physiology & Behavior·J L WeedD K Ingram
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·R S WilsonD A Bennett
Aug 29, 2006·Diabetes Care·K M Venkat NarayanTheodore J Thompson
May 29, 2009·Alzheimer Disease and Associated Disorders·Sandra WeintraubJohn C Morris
Jan 7, 2015·JAMA : the Journal of the American Medical Association·Shona J LivingstoneUNKNOWN Scottish Renal Registry
Oct 29, 2015·The New England Journal of Medicine·Mauro TancrediMarcus Lind
Jan 20, 2016·Science·Matt KaeberleinGeorge M Martin
Aug 16, 2016·Cell·Carlos López-OtínGuido Kroemer
May 30, 2017·Neurochemistry International·Mitsuru Shinohara, Naoyuki Sato
Aug 24, 2018·F1000Research·Thomas van Sloten, Miranda Schram
Sep 7, 2018·Nature·Linda PartridgeP Eline Slagboom
Nov 20, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Li Liu, Richard J Caselli
May 8, 2019·Advances in Experimental Medicine and Biology·Mitsuru Shinohara, Naoyuki Sato
Dec 21, 2019·JAMA : the Journal of the American Medical Association·Yiling J ChengGiuseppina Imperatore
Jan 8, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mitsuru ShinoharaNaoyuki Sato
Mar 7, 2020·The Lancet. Diabetes & Endocrinology·Thomas T van SlotenCoen D A Stehouwer
Aug 30, 2020·Disease Models & Mechanisms·Julia GamacheOrnit Chiba-Falek
Oct 20, 2020·ELife·Mitsuru ShinoharaGuojun Bu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.